These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 28490014)

  • 21. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease.
    Arinze NV; Yin W; Lotfollahzadeh S; Napoleon MA; Richards S; Walker JA; Belghasem M; Ravid JD; Hassan Kamel M; Whelan SA; Lee N; Siracuse JJ; Anderson S; Farber A; Sherr D; Francis J; Hamburg NM; Rahimi N; Chitalia VC
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34752422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
    Ito S; Yoshida M
    Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal Tryptophan Supplementation Protects Adult Rat Offspring against Hypertension Programmed by Maternal Chronic Kidney Disease: Implication of Tryptophan-Metabolizing Microbiome and Aryl Hydrocarbon Receptor.
    Hsu CN; Lin IC; Yu HR; Huang LT; Tiao MM; Tain YL
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aryl Hydrocarbon Receptor Activation and Tissue Factor Induction by Fluid Shear Stress and Indoxyl Sulfate in Endothelial Cells.
    Lano G; Laforêt M; Von Kotze C; Perrin J; Addi T; Brunet P; Poitevin S; Burtey S; Dou L
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How do Uremic Toxins Affect the Endothelium?
    Cunha RSD; Santos AF; Barreto FC; Stinghen AEM
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32575762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients.
    Gryp T; Huys GRB; Joossens M; Van Biesen W; Glorieux G; Vaneechoutte M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cells.
    Addi T; Poitevin S; McKay N; El Mecherfi KE; Kheroua O; Jourde-Chiche N; de Macedo A; Gondouin B; Cerini C; Brunet P; Dignat-George F; Burtey S; Dou L
    Arch Toxicol; 2019 Jan; 93(1):121-136. PubMed ID: 30324315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
    Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resveratrol Rescue Indoxyl Sulfate-Induced Deterioration of Osteoblastogenesis via the Aryl Hydrocarbon Receptor /MAPK Pathway.
    Liu WC; Shyu JF; Lin YF; Chiu HW; Lim PS; Lu CL; Zheng CM; Hou YC; Chen PH; Lu KC
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein-Bound Uremic Toxins and Immunity.
    Rocchetti MT; Cosola C; Ranieri E; Gesualdo L
    Methods Mol Biol; 2021; 2325():215-227. PubMed ID: 34053061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis.
    Shyu JF; Liu WC; Zheng CM; Fang TC; Hou YC; Chang CT; Liao TY; Chen YC; Lu KC
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Resveratrol on Indoxyl Sulfate-Induced Endothelial Hyperpermeability via Aryl Hydrocarbon Receptor (AHR)/Src-Dependent Pathway.
    Assefa EG; Yan Q; Gezahegn SB; Salissou MTM; He S; Wu N; Zuo X; Ying C
    Oxid Med Cell Longev; 2019; 2019():5847040. PubMed ID: 31885805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
    Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aryl hydrocarbon receptor (AhR) and its endogenous agonist - indoxyl sulfate in chronic kidney disease.
    Kamiński T; Michałowska M; Pawlak D
    Postepy Hig Med Dosw (Online); 2017 Jul; 71(0):624-632. PubMed ID: 28791957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease.
    Walker JA; Richards S; Belghasem ME; Arinze N; Yoo SB; Tashjian JY; Whelan SA; Lee N; Kolachalama VB; Francis J; Ravid K; Sherr D; Chitalia VC
    Kidney Int; 2020 Mar; 97(3):538-550. PubMed ID: 31932072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction.
    Fujii H; Goto S; Fukagawa M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
    Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
    Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.